NAS:APLT (USA) Also Trade In: Germany

Applied Therapeutics Inc $ 21.83 -0.06 (-0.27%)

Volume:
58,733
Avg Vol (1m):
126,444
Market Cap $:
490.92 Mil
Enterprise Value $:
378.34 Mil
P/E (TTM):
0.00
P/B:
4.76
Warning! GuruFocus has detected 1 Medium warning sign with APLT. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)
PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for APLT (Applied Therapeutics Inc) from 2019 to Jan 20 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Applied Therapeutics stock (APLT) PE ratio as of Jan 20 2021 is 0. More Details

Applied Therapeutics PE Ratio (TTM) Chart

EMBED

Applied Therapeutics PE Ratio (TTM) Historical Data

Total 441
  • 1
  • 2
  • 3
  • 4
  • 5
Applied Therapeutics PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2021-01-200.0 2020-11-170.0
2021-01-190.0 2020-11-160.0
2021-01-150.0 2020-11-130.0
2021-01-140.0 2020-11-120.0
2021-01-130.0 2020-11-110.0
2021-01-120.0 2020-11-100.0
2021-01-110.0 2020-11-090.0
2021-01-080.0 2020-11-060.0
2021-01-070.0 2020-11-050.0
2021-01-060.0 2020-11-040.0
2021-01-050.0 2020-11-030.0
2021-01-040.0 2020-11-020.0
2021-01-010.0 2020-10-300.0
2020-12-310.0 2020-10-290.0
2020-12-300.0 2020-10-280.0
2020-12-290.0 2020-10-270.0
2020-12-280.0 2020-10-260.0
2020-12-250.0 2020-10-230.0
2020-12-240.0 2020-10-220.0
2020-12-230.0 2020-10-210.0
2020-12-220.0 2020-10-200.0
2020-12-210.0 2020-10-190.0
2020-12-180.0 2020-10-160.0
2020-12-170.0 2020-10-150.0
2020-12-160.0 2020-10-140.0
2020-12-150.0 2020-10-130.0
2020-12-140.0 2020-10-120.0
2020-12-110.0 2020-10-090.0
2020-12-100.0 2020-10-080.0
2020-12-090.0 2020-10-070.0
2020-12-080.0 2020-10-060.0
2020-12-070.0 2020-10-050.0
2020-12-040.0 2020-10-020.0
2020-12-030.0 2020-10-010.0
2020-12-020.0 2020-09-300.0
2020-12-010.0 2020-09-290.0
2020-11-300.0 2020-09-280.0
2020-11-270.0 2020-09-250.0
2020-11-260.0 2020-09-240.0
2020-11-250.0 2020-09-230.0
2020-11-240.0 2020-09-220.0
2020-11-230.0 2020-09-210.0
2020-11-200.0 2020-09-180.0
2020-11-190.0 2020-09-170.0
2020-11-180.0 2020-09-160.0

Applied Therapeutics PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Healthcare » Biotechnology » NAICS : 325412 NAICS : 2834
Traded in other countries 2UV.Germany APLT.USA
Address 545 Fifth Avenue, Suite 1400, New York, NY, USA, 10173
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The lead product candidate of the company is AT-001, which is a novel ARI with broad systemic exposure and peripheral nerve permeability, developed for the treatment of diabetic cardiomyopathy, or DbCM, a fatal fibrosis of the heart.